224 related articles for article (PubMed ID: 17063120)
21. OX40 is a potent immune-stimulating target in late-stage cancer patients.
Curti BD; Kovacsovics-Bankowski M; Morris N; Walker E; Chisholm L; Floyd K; Walker J; Gonzalez I; Meeuwsen T; Fox BA; Moudgil T; Miller W; Haley D; Coffey T; Fisher B; Delanty-Miller L; Rymarchyk N; Kelly T; Crocenzi T; Bernstein E; Sanborn R; Urba WJ; Weinberg AD
Cancer Res; 2013 Dec; 73(24):7189-7198. PubMed ID: 24177180
[TBL] [Abstract][Full Text] [Related]
22. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
23. Postinfection passive transfer of KD-247 protects against simian/human immunodeficiency virus-induced CD4+ T-cell loss in macaque lymphoid tissue.
Murakami T; Eda Y; Nakasone T; Ami Y; Someya K; Yoshino N; Kaizu M; Izumi Y; Matsui H; Shinohara K; Yamamoto N; Honda M
AIDS; 2009 Jul; 23(12):1485-94. PubMed ID: 19528788
[TBL] [Abstract][Full Text] [Related]
24. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
[TBL] [Abstract][Full Text] [Related]
25. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
26. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
27. Increased OX40 and soluble OX40 ligands in children with Henoch-Schonlein purpura: association with renal involvement.
Qin W; Hongya W; Yongjing C; Fang X; Yue M; Xuekun Z; Xiaozhong L; Xueguang Z
Pediatr Allergy Immunol; 2011 Feb; 22(1 Pt 1):54-9. PubMed ID: 21143648
[TBL] [Abstract][Full Text] [Related]
28. Influence of antiretroviral therapy on programmed death-1 (CD279) expression on T cells in lymph nodes of human immunodeficiency virus-infected individuals.
Ehrhard S; Wernli M; Dürmüller U; Battegay M; Gudat F; Erb P
Hum Pathol; 2009 Oct; 40(10):1427-33. PubMed ID: 19439344
[TBL] [Abstract][Full Text] [Related]
29. NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner.
Diana J; Griseri T; Lagaye S; Beaudoin L; Autrusseau E; Gautron AS; Tomkiewicz C; Herbelin A; Barouki R; von Herrath M; Dalod M; Lehuen A
Immunity; 2009 Feb; 30(2):289-99. PubMed ID: 19217323
[TBL] [Abstract][Full Text] [Related]
30. Regulation of CD4 T cell memory by OX40 (CD134).
Salek-Ardakani S; Croft M
Vaccine; 2006 Feb; 24(7):872-83. PubMed ID: 16176850
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract.
Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD
Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189
[TBL] [Abstract][Full Text] [Related]
32. Science gone translational: the OX40 agonist story.
Weinberg AD; Morris NP; Kovacsovics-Bankowski M; Urba WJ; Curti BD
Immunol Rev; 2011 Nov; 244(1):218-31. PubMed ID: 22017441
[TBL] [Abstract][Full Text] [Related]
33. CpG oligodeoxynucleotide-induced immunity prevents growth of germinal center-derived B lymphoma cells.
Ponzio NM; Cutro S; Hu J; Marzouk A; Marshall JD
Int Immunopharmacol; 2006 Dec; 6(13-14):2057-68. PubMed ID: 17161362
[TBL] [Abstract][Full Text] [Related]
34. Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues.
Xie F; Wang Q; Chen Y; Gu Y; Shi Q; Ge Y; Yu G; Wu H; Mao Y; Wang X; Zhou Y; Zhang X
Tissue Antigens; 2006 Apr; 67(4):307-17. PubMed ID: 16634867
[TBL] [Abstract][Full Text] [Related]
35. CLTA-4 blockade in vivo promotes the generation of short-lived effector CD8 T cells and a more persistent central memory CD4 T cell response.
Hokey DA; Yan J; Hirao LA; Dai A; Boyer JD; Jure-Kunkel MN; Weiner DB
J Med Primatol; 2008 Dec; 37 Suppl 2():62-8. PubMed ID: 19187432
[TBL] [Abstract][Full Text] [Related]
36. Decreased levels of alternative co-stimulatory receptors OX40 and 4-1BB characterise T cells from head and neck cancer patients.
Baruah P; Lee M; Odutoye T; Williamson P; Hyde N; Kaski JC; Dumitriu IE
Immunobiology; 2012 Jul; 217(7):669-75. PubMed ID: 22204816
[TBL] [Abstract][Full Text] [Related]
37. Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions.
Kondo K; Okuma K; Tanaka R; Matsuzaki G; Ansari AA; Tanaka Y
Hum Immunol; 2008 Sep; 69(9):533-42. PubMed ID: 18718855
[TBL] [Abstract][Full Text] [Related]
38. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
39. Pre-clinical safety evaluation of heat shock protein 65-MUC1 peptide fusion protein.
Huo Y; Li B; Zhang Y; Wang S; Bao M; Gao X; Li D; Wang L; Yu Y; Wang J
Regul Toxicol Pharmacol; 2007 Oct; 49(1):63-74. PubMed ID: 17600604
[TBL] [Abstract][Full Text] [Related]
40. Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.
Oberst MD; Augé C; Morris C; Kentner S; Mulgrew K; McGlinchey K; Hair J; Hanabuchi S; Du Q; Damschroder M; Feng H; Eck S; Buss N; de Haan L; Pierce AJ; Park H; Sylwester A; Axthelm MK; Picker L; Morris NP; Weinberg A; Hammond SA
Mol Cancer Ther; 2018 May; 17(5):1024-1038. PubMed ID: 29545330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
